Home Newsfeeds Akouos Q2 EPS $(0.58) Up From $(0.66) YoY

Akouos Q2 EPS $(0.58) Up From $(0.66) YoY

Akouos (NASDAQ:AKUS) reported quarterly losses of $(0.58) per share. This is a 12.12 percent increase over losses of $(0.66) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Akouos (NASDAQ:AKUS) reported quarterly losses of $(0.58) per share. This is a 12.12 percent increase over losses of $(0.66) per share from the same period last year.

Housing Market Losing Momentum In Many Key Markets, Analyst Gets Cautious On West Fraser Timber

By Shivani Kumaresan

April 18, 1:51 PM

Credit Suisse analyst reiterated an Outperform rating on the shares of West Fraser Timber Co Ltd (NYSE:WFG) and lowered the price target…

WFG

News

Thorne Research, Inc. Loses Patent Challenge Decision, Upholding ChromaDex’s Intellectual Property Held Under Exclusive License From Dartmouth College

By Benzinga Newsdesk

August 15, 6:38 AM

ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, announced the U.S. Patent & Trademark Office’s Patent Trial and Appeal Board’s

CDXC

FDA Adcomm Gives Thumbs Down To Amgen’s Lumakras For Advanced Form Of Lung Cancer

By Vandana Singh

October 6, 8:59 AM

FDA advisers concluded that the data from a late-stage trial lacked the requisite reliability to endorse the traditional approval of Amgen Inc's (NASDAQ: AMGN) Lumakras for patients afflicted with an advanced

AMGN